Acadia Pharmaceuticals (ACAD) Minority Interest (2012 - 2013)
Acadia Pharmaceuticals (ACAD) posted quarterly Minority Interest of $10.7 million for Q3 2013, down 39.64% quarter-over-quarter from $17.7 million in Q2 2013.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Minority Interest (2012 - 2013) Analysis & Trends
Acadia Pharmaceuticals' Minority Interest history runs 2 years deep, the most recent figure standing at $10.7 million for Q3 2013.
- In Q3 2013, Minority Interest changed N/A year-over-year to $10.7 million; the TTM figure through Sep 2013 stood at $10.7 million (changed N/A YoY), while the FY2012 annual figure was $17.7 million, changed N/A from the prior year.
- Minority Interest for Q3 2013 stood at $10.7 million, down from $17.7 million in the prior quarter.
- The five-year high for Minority Interest was $17.7 million in Q4 2012, with the low at $10.7 million in Q3 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Acadia Pharmaceuticals | 4.82 Bn | 3.86 Bn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2013 | 10.66 Mn |
| Jun 30, 2013 | 17.66 Mn |
| Mar 31, 2013 | 17.66 Mn |
| Dec 31, 2012 | 17.66 Mn |